The Banting Research Foundation and the University of Toronto McLaughlin Centre are pleased to announce that the application period is now open for the 2020 Banting Research Foundation/ McLaughlin Centre Discovery Award. This marks the fourth year of a funding partnership to support research by early career investigators focused on areas relevant to genomic medicine.
The goals of the McLaughlin Centre’s research program are to support new research projects in genomic medicine emphasizing excellence; to educate clinicians, scientists, and health care professionals in genomic medicine; to initiate and promote inter-institutional research activities between McLaughlin Centre partners; to build an enterprise of the highest international reputation and brand; and to ensure the Toronto health-research community leads Canada and the world in delivering 21st-century genomic medicine.
The Banting Research Foundation/ McLaughlin Centre Discovery Award is a one-year grant of up to $25,000 per year that will support research related to genomic medicine, defined as the diagnosis, prognosis, prevention and/or treatment of disease and disorders of the mind and body, using approaches informed by knowledge of the diploid genome and the molecules it encodes. The study of any model system genome relevant to biomedical research is also eligible.
The Banting Research Foundation/ McLaughlin Centre Discovery Award will be awarded through the Discovery Award program of the Banting Research Foundation. Eligible applicants must be in the first three years of an academic appointment at the University of Toronto or its affiliated hospitals and their research institutes. For complete guidelines and application instructions, click here.
Application deadline: February 14, 2020
